Application

15495474 · NANOPARTICLE-BASED TUMOR-TARGETED DRUG DELIVERY

Filed 2017-04-24 · Granted · Patent 10335420 (2019-07-02) The official file ↗The patent and its PDF ↗ · Art unit 1612 · Examiner Michael P Cohen Typical · CPC A61K 9/127 · The Scripps Research Institute · Olson & Cepuritis, LTD.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

10.6 mo

to disposition 26.3 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.